Document is current
Any future updates will be listed below
-
Authors
Venturi, Giulietta
Gallinaro, Alessandra
Fortuna, Claudia
Pirillo, Maria Franca
Scoglio, Arianna
Di Carlo, Beatrice
Marsili, Giulia
Michelini, Zuleika
Amendola, Antonello
Carocci, Alberto
Dispinseri, Stefania
Borghi, Martina
Canitano, Andrea
Falce, Chiara
Zappitelli, Alice
Scarlatti, Gabriella
Lixi, Maria Luisa
Aste, Alessandra
Masala, Laura
Baroncelli, Silvia
Cara, Andrea
Negri, Donatella
-
Funding
Funding for this research was provided by:
EU funding within the Next Generation EU-MUR PNRR (PE00000007, PE00000007)
OSR-UniSR and Ministero della Salute (COVID-2020-12371617)
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 12 February 2025
First Online: 24 February 2025
Declarations
:
: The authors declare no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The subjects belonged to the Ospedale SS Trinità. The observational and retrospective study “COVID-IMM: Analisi della risposta IMMunologica nei sieri di pazienti COVID-19” has been approved by the ATS Sardegna Ethics Review Board (protocol 260/2020). COVID-19 Patients characterization, Biobank, Treatment response and Outcome Predictor [COVID-BioB], EC protocol number 34/int/2020, clinicalTrials.gov NCT04318366.
: Informed consent was obtained from all participants included in the study.
